Inozyme Pharma

INZY

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-104.03M

EBITDA$-95.16M

EBIT$-96.47M

Pre-tax Income$-106.72M

Net Income$-102.02M

Cash Equivalent$20.69M

Total Debt$46.75M

Book Value$88.47M

Book Value Per Share1.41

Return on Equity (ROE)-176.43%

Return on Assets (ROA)-82.82%

Return on Invested Capital (ROI)-98.30%

Net Profit Marginundefined

Current Ratio3.56

Quick Ratio3.36

Long-Term Debt / Equity0.54